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Impact of bariatric surgery 
on obstructive sleep apnea 
severity and continuous positive 
airway pressure therapy 
compliance—prospective 
observational study
Paweł Nastałek1*, Kamil Polok1, Natalia Celejewska‑Wójcik1, Aleksander Kania1, 
Krzysztof Sładek1, Piotr Małczak2 & Piotr Major2
To evaluate association between bariatric surgery and changes in obstructive sleep apnea (OSA) 
severity and sleep architecture was as well as to asses continuous positive airway pressure (CPAP) 
effectiveness and compliance. We enrolled patients undergoing bariatric surgery. Polysomnography 
was performed in each patient preoperatively and 12 months after the procedure in a subgroup of 
patients diagnosed with OSA. STOP‑BANG, Epworth Sleepiness Scale (ESS) and Berlin questionnaire 
scores were obtained pre‑ and postoperatively. CPAP compliance data was recorded during follow‑up 
hospitalization. Among 44 patients with median age of 49.5 years, predominantly women (68.2%) 
pre‑ and postoperative polysomnography was performed. We observed significant improvement in 
STOP‑BANG (6.0 vs. 3.0, p < 0.001) and ESS (12.0 vs. 5.0, p < 0.001) scores, apnea–hypopnea index 
(44.9 vs. 29.2, p < 0.001), oxygen desaturation index (43.6 vs. 18.3, p < 0.001) and sleep architecture 
parameters. CPAP compliance was poor with a median percentage of days with CPAP use accounting 
to 49.3%. Bariatric surgery is associated with a significant decrease in the number of sleep‑related 
respiratory disturbances, as well as improvement of sleep efficiency. Postoperative CPAP therapy 
compliance was poor despite low rate of OSA resolution. This study suggests that patients with OSA 
undergoing bariatric surgery require postoperative reassessment.
Obesity represents a major global health challenge with estimated 650 million cases  worldwide1. Its prevalence 
varies significantly depending on a country and ranges from 3.7% in Japan to 38.2% in the United  States2,3. 
Obesity is a key risk factor for multiple diseases such as hypertension, diabetes, stroke, osteoarthritis and cancer, 
thus leading to premature disability and  death4. It is considered the most important, best documented and one 
of the few modifiable risk factors for obstructive sleep apnea (OSA).
OSA is the most common manifestation of sleep breathing disorders and affects 4% males and 2% females 
in the general  population5,6. Untreated OSA is associated with a decline in quality of life, development of several 
cardiovascular comorbidities, increased risk of car accidents and premature  mortality7. The gold standard for 
OSA treatment is continuous positive airway pressure (CPAP)5. Meta-analyses of randomized controlled trials 
proved the effectiveness of CPAP in attenuation of sleep apnea, reduction of OSA symptoms and OSA-associated 
 comorbidity8.
Bariatric surgery is currently considered the most effective modality of obesity treatment, associated with 
long-term maintenance of body weight  reduction9. It is indicated in patients with BMI > 40 kg/m2 or BMI > 35 kg/
m2 accompanied by comorbidities i.e. heart failure, type 2 diabetes, hypertension and  OSA10. Untreated OSA 
in obese individuals qualified for bariatric surgery is related to increased risk of complications in perioperative 
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 period11. Preoperatively initiated and effective CPAP therapy reduces the risk of complications associated with 
general anesthesia as well as the bariatric procedure  itself12.
Despite the beneficial effects of weight reduction on sleep breathing disorders confirmed by number of 
studies, there is still significant uncertainty whether bariatric surgery eliminates OSA and allows CPAP therapy 
discontinuation. This study was an attempt to elucidate above mentioned issues. The primary aim of this study 
was to assess the association between bariatric surgery and the severity of sleep-related disturbances.
Materials and methods
Study design. This was a single-centre observational study including obese patients undergoing primary 
bariatric surgery. Preoperative evaluation of OSA risk using validated screening tools and polysomnography 
were routinely performed in the Pulmonology Department. If a patient met obstructive sleep apnea diagnostic 
criteria and required PAP therapy, CPAP was introduced and titrated. After the index procedure in the 2nd 
Department of Surgery each patient diagnosed with OSA was referred to the Pulmonology Department for fol-
low-up reassessment within 12 months after the index procedure including sleep questionnaires and polysom-
nography. Moreover, the CPAP compliance data from patients` CPAP devices was downloaded and analysed. 
If persistent sleep apnea requiring CPAP therapy was present in follow-up polysomnography, we performed a 
re-titration of therapeutic CPAP.
Patients that finally did not undergo surgery, who did not meet the criteria of OSA (apnea–hypopnea index 
[AHI] < 5/h) or missed the follow up hospitalisation were excluded from final analysis. The data was collected 
between December 2014 and May 2018. The study complies with the Declaration of Helsinki. All patients gave 
informed consent to participate in the study and official approval for the study protocol from the Jagiellonian 
University Ethics Committee was obtained (KBET/126/B/2014).
Study subjects’ characteristics. On admission to the Pulmonology Department clinical characteris-
tics of study subjects including demographic data (age, gender), physical examination (blood pressure, heart 
rate, haemoglobin saturation, patient`s height and weight) and comorbidities (history of diabetes, pre-diabe-
tes, hypertension, atrial fibrillation, chronic heart failure, coronary artery disease, osteoarthritis, smoking) was 
obtained. American Society of Anaesthesiologists Classification (ASA) score records were gathered from 2nd 
Department of General Surgery for individuals who eventually underwent bariatric surgery procedure.
Questionnaires. Patients were assessed using validated screening tools: STOP-BANG questionnaire, Berlin 
questionnaire and Epworth Sleepiness Scale (ESS)13–15. The STOP-BANG questionnaire includes four questions 
related to snoring (S), tiredness (T), observed apnea (O), high blood pressure (P) and additional anatomical 
and demographic queries; BMI (B), age (A), neck circumference (N) and male gender (G). For each question, 
answering “yes” scores 1, a “no” response scores 0, with cut-off score for increased OSA risk ≥ 313. The Berlin 
questionnaire is a self-administered questionnaire which consists of 10 questions in three categories related to 
the presence and severity of snoring, frequency of daytime sleepiness, and the presence of obesity or hyperten-
sion. In category one, high risk was defined as persistent symptoms in two or more questions related to snoring. 
In category two, high risk was defined as persistent daytime sleepiness, drowsiness while driving, or both. In 
category three, high risk was defined as a history of hypertension or a BMI higher than 30 kg/m2. High-risk sub-
jects for OSA were those who were defined as high risk in at least two out of three  categories14. ESS is a simple, 
self-administered questionnaire which is shown to provide a measurement of the subject’s general level of day-
time sleepiness during certain activities (watching TV, reading a book, travelling, driving etc.). Patient evaluated 
chance of dozing scoring from ‘’0′’ that indicates “no chance of dozing” to “3” that means high dozing chance. 
Result ≥ 10 indicates excessive daytime sleepiness that might be associated with  OSA15.
Obstructive sleep apnea diagnosis and treatment. Polysomnography was performed using a 
31-channel polysomnographic system (Phillips ALICE 6LDe) system. Detection of apneas and hypopneas as 
well as diagnosis of OSA and its severity assessment were performed in accordance with current American 
Academy of Sleep Medicine  criteria16. Each polysomnography was assessed by a pulmonologist certified in sleep 
medicine. Titration of therapeutic CPAP was performed using automatic CPAP machine (Philips Respironix 
REMstar Auto A-flex Series 60 device) coupled with polysomnography. CPAP recordings were analysed using 
Philips Encore Software.
Bariatric surgery. The surgical technique has been described in detail  previously17. A Veress needle was 
used to achieve pneumoperitoneum (15  mmHg). The routine procedure required insertion of four trocars 
during laparoscopic sleeve gastrectomy (LSG) and five trocars during laparoscopic Roux-en-Y gastric bypass 
(LRYGB). A sealer/divider or ultrasonic shears were used for dissection and coagulation. A 34-French gastric 
bougie was used to calibrate the gastric sleeve. Gastrectomy started 4–5 cm proximal to the pylorus with contin-
uously applied linear staples straight to the angle of His. The staple line was reinforced by a running suture. The 
resected portion of the stomach was removed from the peritoneal cavity through the left flank trocar site during 
LSG. LRYGB required creation of a pouch by one horizontal 45-mm stapler followed by vertical stapling toward 
the angle of His, until the pouch was totally separated from the rest of the stomach. A gastrojejunal anastomosis 
was created with a linear stapler with hand-sewn closure of the remaining defect. The length of the alimentary 
and enzymatic limb was standardized in all patients as 150 and 100 cm, respectively. A jejunojejunal anastomosis 
was created using a linear stapler. A routine 10- or 12-mm port site closure was performed to prevent herniation. 
Perioperative care in our department is based on ERAS  guidelines18,19.
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Statistical analysis. Categorical variables were presented as counts (%) and compared using chi-square 
test, while continuous variables were presented as median (interquartile range) and compared using Mann–
Whitney U test unless otherwise specified. Differences between dependent continuous variables with non-
normal distribution were assessed using Wilcoxon test. Correlation between two variables with non-normal 
distribution was assessed using Spearman`s Rank test. A two-sided p-value of 0.05 was considered statistically 
significant. It was a complete-case analysis. Patients with missing postoperative BMI values (n = 3) were excluded 
from analyses including this variable. Statistical analysis was performed using Statistica 13 software. Graphs were 
created with GraphPad Prism 8.3.
Ethics approval. Approval for the study protocol was obtained from the Jagiellonian University Ethics 
Committee was obtained (KBET/126/B/2014).
Consent to participate. All patients signed an informed consent.
Results
Study group characteristics. We enrolled 191 patients with preoperative polysomnography, of whom 43 
(22.5%) patients eventually did not undergo bariatric surgery. Among the remaining 148 individuals who under-
went bariatric surgery, 112 (75.7%) patients were diagnosed with obstructive sleep apnea and were referred to 
the pulmonology clinic for the follow-up hospitalization, of whom 44 patients (39.3%) were finally reassessed 
and included in the final analysis. Detailed information can be found in the study flowchart (Fig. 1).
The study group included patients at the median age of 49.5 (41.5–57.5) years, 14 (31.8%) of whom were male. 
The most common comorbidities were hypertension (31/44, 70.5%), diabetes (18/44, 40.9%) and dyslipidemia 
(17/44, 38.6%). Majority of patients underwent laparoscopic sleeve gastrectomy (31/44, 70.5%), while laparo-
scopic Roux-en-Y gastric bypass was performed in the remaining 13 patients (29.5%). Detailed study participant 
characteristics are presented in Table 1.
Preoperative sleep Apnea diagnosis and CPAP therapy initiation. Preoperative polysomnography 
revealed mild, moderate and severe obstructive sleep apnea in 1 (2.3%), 7 (15.9%) and 36 (81.8%) patients 
respectively.
We observed a significant improvement in AHI (44.9 vs. 3.2, p < 0.001), oxygen desaturation index (ODI; 
43.6 vs. 6.7, p < 0.001) and mean  SpO2 (93.0 vs. 94.0, p < 0.001) during polysomnography coupled with automatic 
Figure 1.  Study flowchart. N, number of patients.
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CPAP compared to baseline polysomnography. Normalization of breathing disturbances (defined as AHI < 5/
hour) was achieved in 25 (56.8%) patients. The median titrated therapeutic CPAP was 8.3 mbar (7.0–10.0).
Comparison of pre‑ and postoperative polysomnography results and scales scores. We 
observed a significant improvement in majority of polysomnography parameters, e.g., AHI (44.9 vs. 29.2, 
p < 0.001), ODI (43.6 vs. 18.3, p < 0.001), mean hemoglobin oxygen saturation (93.0 vs. 95.0, p < 0.001) and snor-
ing (21.6 vs. 4.5%, p < 0.001). Detailed results are summarized in Table 2. Changes in AHI, ODI, BMI and time 
in bed with haemoglobin saturation below 90% are visualized in Fig. 2. We found no correlation (ρ 0.25, p = 0.11) 
between absolute change in BMI (postoperative BMI—preoperative BMI) and absolute change in AHI (postop-
erative AHI—preoperative AHI). The percentage loss of excess AHI was moderately correlated with percentage 
loss of excess BMI (ρ 0.63, p < 0.001) and weakly negatively correlated with age (ρ − 0.34, p = 0.024). There were 
no differences in percentage loss of excess AHI between males and females (37.6 vs. 54.7/h, p = 0.39) as well as 
between patients with the predominance of hypopneas defined as HI/AI index > 1, and those with predominance 
of apneas, defined as HI/AI index < 1 (49.0 vs. 38.8/h, 0.90). Above mentioned correlations and comparisons are 
presented in Fig. 3.
Bariatric surgery was associated with significant improvement of sleep efficiency (73.4% vs 86.7%, p = 0.016) 
and significant decrease in number of respiratory related arousals (16.8 vs 6.7, p < 0.001) and total number of 
arousals (36.8 vs 23.8, p = 0.03). Detailed results are summarized in Table 2.
We performed an additional analysis of changes in disease severity before and after bariatric surgery. OSA 
severity category decreased in 17 (38.6%) patients, increased in 2 (4.5%) patients and did not change in 18 
(40.9%) patients. Normalization of sleep disturbances was observed in 7 (15.9% patients).
We observed significant decrease in both STOP-BANG (6.0 vs. 3.0, p < 0.001) score and Epworth Sleepiness 
Scale (12.0 vs. 5.0, p < 0.001) as well as decrease in proportion of patients assessed as high risk according to Berlin 
Table 1.  Demographic and clinical characteristics of the study group. ASA, American Society of 
Anesthesiologists; LSG, laparoscopic sleeve gastrectomy; LRYGB, laparoscopic Roux-en-Y gastric bypass.
Characteristic Patients (N = 44)
Demographic
Age (years) 49.5 (41.5–57.5)
Gender, male 14 (31.8%)
Preoperative assessment
Maximal recorded body mass index (kg/m2) 47.2 (42.6–53.1)
Body mass index on admission (kg/m2) 45.0 (40.8–50.6)
Systolic blood pressure (mmHg) 130.0 (120.0–150.0)
Diastolic blood pressure (mmHg) 80.0 (80.0–90.0)
Heart rate (beats/min.) 78.0 (70.0–88.0)
Hemoglobin oxygen saturation (%) 98.0 (96.0–98.0)







Atrial fibrillation 3 (6.8%)
Chronic heart failure 1 (2.3%)
Varicose veins 9 (20.5%)
Smoking 7 (15.9%)
Coronary artery disease 0 (0.0%)
Scale scores
Berlin questionnaire, high risk 41 (93.2%)
STOP-BANG (pts) 6.0 (5.0–7.0)
Epworth Sleepiness Scale (pts) 12.0 (9.0–14.0)




Surgery duration (min.) 95.0 (72.5–120.0)
Length of hospitalization (days) 3.0 (2.0–4.0)
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questionnaire (93.2% vs. 29.5%). Excessive daytime sleepiness, defined as ≥ 10 points in ESS, was present in 30 
patients preoperatively (68.2%) and in 3 patients after bariatric surgery (6.8%). Differences in scales scores before 
and after surgery are presented in Fig. 4.
CPAP compliance and effectiveness. Compliance reports from patients’ CPAP devices were available in 
36 patients. Median percentage of days with CPAP use accounted to 49.3% (15.8–76.0%), among which median 
percentage of days with CPAP use exceeding 4 h a day was 87.3% (35.9–97.3%). Effectiveness of therapy was 
reflected by median AHI during CPAP use accounting to 1.2 (0.4–2.3). We observed a significant reduction in 
therapeutic CPAP values (9.0 vs 6.3, p < 0.001) during re-titration with automatic CPAP coupled polysomnog-
raphy.
Discussion
In this prospective observational study, including 148 patients undergoing elective bariatric surgery, OSA was 
diagnosed in over 75% individuals, with the majority of cases being severe. Based on postoperative polysom-
nography, performed in 44 individuals, we demonstrated that bariatric surgery does not sufficiently reduce OSA, 
despite certain improvement in disease symptoms as perceived by patients, which possibly translates to prema-
ture discontinuation of CPAP therapy. In this study we showed that patients with OSA who underwent bariatric 
Table 2.  Preoperative and postoperative PSG parameters. AI, apnea index; AHI, apnea–hypopnea index; 
CAI, central apnea index; HI, hypopnea index; HR, heart rate; NREM, non-rapid eye movement sleep; OAI, 
obstructive apnea index; ODI, oxygen desaturation index; REM, rapid eye movement sleep ;SpO2, hemoglobin 
oxygen saturation.
Parameter Preoperative values Postoperative values P value
Respiratory disturbances
AHI (/h) 44.9 (30.8–63.7) 29.15 (11.1–3.65)  < 0.001
OAI (/h) 12.2 (5.1–29.4) 4 (0.5–15.2)  < 0.001
CAI (/h) 1.1 (0.2–2.95) 0.65 (0–2.15) 0.09
AI (/h) 16.5 (5.6–35.3) 6.4 (1.2–17.3)  < 0.001
HI (/h) 24.9 (14.5–29.75) 13.65 (6.9–24.95) 0.007
AHI REM sleep (/h) 44.1 (26.25–70.1) 21.1 (6–52.8) 0.002
AHI NREM sleep (/h) 42.15 (31.45–62.95) 27.55 (9.55–43.9)  < 0.001
AI REM sleep (/h) 18 (6.4–34.15) 5.3 (0–22)  < 0.001
AI NREM sleep (/h) 17.6 (6.7–35.05) 5.2 (1.05–16.45) 0.002
HIREM sleep (/h) 19.55 (11.9–39.6) 11.3 (2.5–24.7) 0.07
HI NREM sleep (/h) 23 (12.5–29.4) 15.5 (6.6–25.7) 0.11
AHI supine position (/h) 49.15 (36.1–71) 29.65 (9.3–47.9)  < 0.001
Nocturnal pulseoxymetry
ODI (/h) 43.6 (27.15–71) 18. 25 (6.65–31.6)  < 0.001
ODIREM sleep (/h) 41.65 (31.55–78.05) 15.8 (4–50.3)  < 0.001
ODI NREM sleep (/h) 41.1 (27.45–65.2) 18 (4.85–33.05)  < 0.001
Mean  SpO2 (%) 93 (91–94) 95 (93–96)  < 0.001
Minimal  SpO2 (%) 76 (67.5–82) 83.5 (81–90)  < 0.001
Time with  SpO2 < 90% (min.) 46.85 (14.75–91.9) 2.75 (0.05–20.4)  < 0.001
Mean HR (beats/min.) 69 (61.75–75.5) 61.1 (56.9–65.3)  < 0.001
Minimal HR (beats/min.) 50 (42–56) 51 (47.1–56) 0.17
Maximal HR (beats/min.) 127.5 (109–154) 109.5 (102–121.3) 0.054
Sleep architecture
Sleep efficiency (%) 73.35 (64.05–87.4) 86.65 (70.7–94.95) 0.016
Sleep latency (min.) 24 (11.9–35.1) 17.25 (10–24.25) 0.11
REM sleep latency (min.) 75.75 (61–114.75) 75 (55–110) 0.65
NREM 1 sleep (%) 22.5 (15.25–29) 26.55 (21.4–33.25) 0.015
NREM 2 sleep (%) 44.25 (35.9–50.45) 45.95 (38.3–53.05) 0.55
NREM 3 sleep (%) 19.15 (12.35–23.35) 13 (7.5–20) 0.003
REM sleep (%) 10 (5.55–14.6) 11.15 (7.45–15.05) 0.50
Respiratory arousals (/h) 16.8 (9.1–35.2) 6.7 (3.2–12.6)  < 0.001
Spontaneous arousals (/h) 9.7 (5.95–14.5) 12 (6.3–22.2) 0.37
Arousals index (/h) 36.85 (17.55–54.3) 23.8 (13.45–45.45) 0.030
Snoring (% of sleep time) 21.6 (15–31.1) 4.45 (0.15–12.15)  < 0.001
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surgery require postoperative reassessment in order to evaluate indications for CPAP therapy, its effectiveness 
and patients` compliance.
Polysomnography performed one year after index surgery demonstrated that bariatric surgery significantly 
reduces respiratory disturbances during sleep but does not entirely eliminate OSA. Normalization of respiratory 
disturbances during sleep was observed in only 16% of patients while severity of OSA increased, remained stable, 
and decreased without normalization in 5%, 39%, and 41% respectively. In the presented study we attempted 
to assess factors potentially associated with the success of bariatric surgery in terms of decrease in AHI. Our 
results suggest that the proportion of excess AHI lost after the index surgery is moderately associated with post-
operative reduction in excess BMI and weakly negatively correlated with age, however we found no significant 
relation with sex and predominance of hypopneas or apneas. Further studies should focus on search for factors 
predicting failure of bariatric surgery in improving sleep disturbances, because it may optimize the selection of 
patients requiring particular attention of sleep medicine specialists in the follow-up. Impact of bariatric surgery 
on OSA was evaluated in number of systematic  reviews9,20–23 and original  studies24–29, including randomized 
controlled  trials30,31, concluding that majority of OSA patients do not achieve OSA resolution after bariatric 
surgery. The postoperative AHI shown in presented study is generally consistent with available literature, already 
mentioning the problem of residual OSA, however its extent seems to be higher than previously reported. This 
is probably related to higher baseline AHI values and higher prevalence of severe OSA in our cohort, compared 
to previously published  papers9,20–29.
One of the main advantages of our study is comprehensive evaluation of perioperative changes in all poly-
somnography parameters, while the majority of available data is based solely on perioperative changes in AHI, 
patient-reported OSA remission or sleep questionnaires results. There is limited data documenting the influence 
of bariatric surgery on sleep architecture, since vast majority of authors analysed only respiratory PSG parameters 
without appropriate evaluation of perioperative changes in sleep architecture. In the present study we found 
that postoperative weight loss improves sleep quality, which is reflected by a significant improvement of sleep 
efficiency and decrease in number of respiratory related arousals and total number of arousals.
In parallel to improvement in sleep architecture, we found that bariatric surgery was associated with marked 
alleviation of excessive daytime sleepiness (EDS) quantified with Epworth Sleepiness Scale, reduction of OSA 
symptoms based on STOP-BANG questionnaire as well as decrease in proportion of patients assessed as high 
risk according to Berlin questionnaire. It is estimated that EDS is present in about 30% of obese individuals with 
BMI > 35 kg/m2 and might be independent from OSA  presence32. The postulated EDS and obesity relationship 
could be explained by multiple pathophysiological mechanisms including overactivity of autonomic nervous 
system, hormonal and metabolic changes and obesity-related medical  conditions33–35. Impact of weight loss on 
aforementioned pathways could partially clarify beneficial impact of bariatric surgery on EDS. Interestingly, 
there is data suggesting that the phenomenon of dramatic improvement of EDS related to weight reduction 
Figure 2.  Perioperative changes in apnea–hypopnea index, oxygen desaturation index, body mass index and 
time in bed with hemoglobin saturation below 90%. AHI, apnea–hypopnea index; BMI, body mass index; ODI, 
oxygen desaturation index; TIB, time in bed;  SpO2, hemoglobin oxygen saturation.
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may occur regardless of OSA  resolution34,35. The results of presented study might support the theory that EDS 
resolution does not fully correspond to change in apnea severity, since we demonstrated that bariatric surgery 
actually reduces EDS without satisfactory resolution of respiratory disturbances. Thus, diminished EDS related 
to bariatric surgery might rather be a result of more efficient sleep with less arousals. It has also been suggested 
that EDS in obese patients may depend on the level of nocturnal  hypoxia32. In our study we demonstrated that 
bariatric surgery was associated with significant improvement of median and minimal  SpO2 values and total 
time with  SpO2 value < 90%. Moreover, the observed reduction of hypoxia duration and number of desaturation 
events was much more prominent than perioperative AHI decrease. These findings raise the question about the 
validity of OSA classification based only on AHI, thus omitting severity of hypoxia, which undoubtedly plays 
crucial role in pathogenesis of OSA symptoms and comorbidity. In our opinion, presented results suggest the 
need for routine postoperative PSG in order to precisely re-evaluate the severity of respiratory disturbances at 
Figure 3.  Percentage loss of excess AHI correlated with percentage loss of BMI (A), age (B) and compared 
between females and males (C) as well as patients with hypopnea index/apnea index ratio > 1 and < 1 (D). AI, 
apnea index; AHI, apnea–hypopnea index; BMI, body mass index; HI, hypopnea index. Red lines in A and B 
represent lines of best fit, while black horizontal lines in (C and D) represent median.




Scientific Reports |         (2021) 11:5003  | https://doi.org/10.1038/s41598-021-84570-6
www.nature.com/scientificreports/
least among patients diagnosed with severe OSA regardless of the postoperative weight loss or patient-reported 
alleviation of symptoms.
The present study also addressed the issue of premature postoperative CPAP cessation and poor CPAP com-
pliance in patients with OSA undergoing bariatric procedures. We confirmed the effectiveness of CPAP therapy 
in this population with significant improvement of all crucial PSG parameters. Patients diagnosed with OSA 
were recommended to adhere to CPAP treatment preoperatively with indication to continue therapy for at least 
12 months after bariatric surgery. The compliance reports obtained from patients’ CPAP devices at follow up visit 
were available in 36 cases. We proved high effectiveness of CPAP therapy reflected by median AHI accounting 
to 1.2/h (0.4–2.3/h) during CPAP. Unfortunately, compliance defined by median percentage of days with CPAP 
use accounted to less than 50%. We believe that actual CPAP compliance was even lower since great number 
of patients were excluded from the final analysis due to lack of postoperative PSG. There are published data 
indicating poor long-term CPAP compliance and problem of premature treatment discontinuation in general 
OSA  population36,37. This also applies to OSA patients treated with bariatric surgery. Moreover, patients with 
sleep apnea who underwent bariatric surgery tend to discontinue CPAP therapy more frequently than other 
OSA patients and this phenomenon must not be  underestimated38. Some authors suggested that CPAP therapy 
discontinuation after bariatric surgery may have a negative impact on the obesity-related comorbidities and 
increase the risk of OSA-associated complications. The factor potentially influencing CPAP compliance may 
be a reduction of therapeutic CPAP values after bariatric surgery confirmed in postoperative CPAP titration 
performed simultaneously with PSG. Preoperatively titrated CPAP pressure may turn out to be too high after 
significant weight loss, leading to poor tolerance of CPAP therapy and its premature discontinuation. However, 
in the present study vast majority of patients were treated with automatic CPAP devices (APAP), thus eliminating 
the need to modify the therapeutic CPAP pressure during 12-month follow-up period in contrast to traditional 
fixed pressure CPAP devices. Despite this fact, the CPAP compliance remained poor. Thus, the question which 
PAP therapy is the most suitable for OSA patients undergoing bariatric surgery remains unanswered, due to lack 
of studies directly comparing compliance with different CPAP devices in this setting. That also clearly indicates 
that problem of CPAP cessation after BS is multifactorial and warrants further investigation.
The undoubted advantage of this study is detailed evaluation of study cohort in tertiary centre sleep labora-
tory including fully supervised polysomnography (PSG), availability of comorbidity history, results of several 
types of sleep questionnaires, and CPAP therapy compliance data. However, there is one important limitation. It 
must be emphasized that from initially enrolled 148 individuals with preoperative PSG only 44 (40%) attended 
12-month follow up hospitalization with postoperative PSG, which is an interesting observation itself. It might 
indicate a necessity for more frequent and probably more effectively enforced follow-up visits after bariatric 
surgery accompanied by CPAP compliance analysis and identification of possible problems influencing CPAP 
therapy (value of pressure, mask fit, psychological factors affecting CPAP usage). Simultaneously we should pay 
careful attention to patient re-education emphasizing the risk of OSA complications potentially associated with 
premature CPAP cessation and fact of high frequency of persistent asymptomatic OSA.
Conclusions
This study suggests that bariatric surgery does not sufficiently reduce obstructive sleep apnea what warrants man-
datory postoperative polysomnography in order to precisely re-evaluate at least all severe OSA patients regardless 
of the postoperative weight loss or patient-reported resolution of symptoms. Moreover, sleep questionnaires are 
probably not a reliable tool for evaluation of persistent OSA after bariatric surgery. Patients with OSA undergo-
ing bariatric surgery are characterized by poor CPAP compliance what indicates the need for proper education 
and early follow-up visits with identification of potential factors influencing the therapy.
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